Literature DB >> 7436738

Tumors induced by progressor sarcoma virus (Moloney) in mice: growth in the presence of an immune response and isolation of autonomously growing cells.

E Weiland, M Mussgay.   

Abstract

Courses of tumors, which had been induced in adult STU mice with a regressor and with a progressor strain of Moloney sarcoma virus (MSV-M) were followed and compared. All 73 tumors induced by the regressor strain of MSV-M (R-MSV-M) regressed and 181 of 183 tumors induced by a progressor strain (P-MSV-M) grew progressively and killed their hosts between 16 and 171 days after infection. Even after inoculation of about 4 FFU of P-MSV-M tumor development may occur and lead to progressively growing tumors. Both strains of MSV-M induce strong immune responses in their host, namely cytotoxic effector cells, cytotoxic antibodies and tumor resistance. Simultaneous injection of mice on separate sites with P-MSV-M on one side and R-MSV-M producing ascitic cells on the other side did not induce mutual influences on the different tumor courses. It is therefore concluded that the immune response is obviously not decisive for the failure of P-MSV-M induced tumors to regress. From seven P-MSV-M induced primary tumors two producer and five nonproducer transformants could be isolated, maintained in culture and partly held as easily transplantable tumors in adult immunocompetent mice. Both producer transformants release sarcoma virus with the capacity to induce progressively growing tumors in adult mice. All transformants induce progressively growing tumors after transplantation independent of the applied cell dose. It is concluded that the ability of the P-MSV-M to induce stably transformed cells (in contrast to R-MSV-M, WEILAND et al., Brit. J. Cancer, 1979) favours clonal development and ultimately progressive tumor course, in spite of the presence of an immune response.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7436738     DOI: 10.1007/bf01315040

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

1.  Pathologic and virologic studies of tumors induced in mice by two strains of murine sarcoma virus.

Authors:  P J Simons; D J McCully
Journal:  J Natl Cancer Inst       Date:  1970-06       Impact factor: 13.506

2.  Demonstration of a cell-surface antigen associated with murine sarcoma virus by immunoelectron microscopy.

Authors:  T Aoki; J R Stephenson; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1973-03       Impact factor: 11.205

3.  A quantitative study on transformation of hamster embryo cells in vitro by murine sarcoma viruses (Harvey and Moloney).

Authors:  R C Ting; A V Bader
Journal:  Virology       Date:  1969-10       Impact factor: 3.616

4.  [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].

Authors:  E Weiland; F Weiland
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1974-11

Review 5.  The murine sarcoma virus-induced tumor: exception or general model in tumor immunology?

Authors:  J P Levy; J C Leclerc
Journal:  Adv Cancer Res       Date:  1977       Impact factor: 6.242

6.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

7.  Detection of cytotoxic lymphoid spleen cells from STU-mice with Moloney sarcoma by a 3H-proline microcytotoxicity assay.

Authors:  E Weiland; M Mussgay
Journal:  Med Microbiol Immunol       Date:  1976-06-01       Impact factor: 3.402

8.  Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors.

Authors:  E Weiland; M Mussgay
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-11

9.  Growth pattern of tumours in mice induced by murine Moloney sarcoma-virus and sarcoma-virus-transformed cells.

Authors:  F Weiland; E Weiland; M Mussgay
Journal:  Br J Cancer       Date:  1979-12       Impact factor: 7.640

10.  Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells.

Authors:  J R Stephenson; S A Aaronson
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

View more
  2 in total

1.  Transformed cell lines derived from progressor Sarcoma virus (Moloney) induced tumors. I. Differences in pathogenicity between C type viruses from producer and helper virus infected nonproducer cells.

Authors:  E Weiland; M Mussgay
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

2.  Detection and preliminary characterization of a transmissible agent inducing autoantibody against Golgi-antigen.

Authors:  E Weiland; F Weiland
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.